GLP-1 Therapy for Patients with Obesity: Identifying Solutions to Optimize Nutrition

Required Reading!
GLP-1 Therapy for Patients with Obesity: Identifying Solutions to Optimize Nutrition
Course Expires September 11, 2028
Credits: 3.75
Accreditations: CDR, CBDCE
Required Reading

Purchase this Product

Become a Member

Learn to address challenges associated with the use of GLP-1 medications in the treatment of obesity!

Course Description

This self-study course is based on required reading that was written by a group of expert clinicians. It provides practical strategies and priorities to enhance the care of patients who have been prescribed GLP-1 medications. The article reviews pertinent side effects and key challenges that are commonly seen within this patient population, while also clearly outlining relevant nutrition-related recommendations and potentially successful interventions.

After reviewing the required reading, learners will evaluate their knowledge through the continuing professional education self-assessment test. This case-study based exam will assess the learner’s understanding of evidence-based nutrition priorities that can be utilized to address challenges associated with the use of GLP-1 medications in the treatment of obesity.

The required reading serves as an invaluable reference for registered dietitian nutritionists, certified diabetes educators, nutrition and dietetic technicians, registered and nutrition educators. The case-study based continuing professional education (CPE) exam reviews key aspects of the text and assists the learner with practical application of the content.

Purchasing Options: This is available as eDocument plus CPE Test only. Includes a link to the required reading in the course document, electronic test, and 1 certificate with passing grade.

After completion of this CPE program, the participants will be able to:

  1. Integrate new knowledge and skills related to the care of patients prescribed GLP-1 medications into practice.
  2. Analyze and synthesize information regarding the use of GLP-1 medications and identify new information, patterns, and findings that can inform priority nutrition interventions for patients utilizing these medications.
  3. Seek new scientific information about the treatment of obesity, including the use of GLP-1 medications, and analyze how it impacts medical nutrition therapy.
  4. Prioritize nutrition problems specific to the use of glucagon-like peptide 1 receptor agonist (GLP-1) therapy to inform nutrition care plans and processes.

This course is intended for: RDNs, CDCESs and NDTRs

GLP-1 Therapy for Patients with Obesity: Identifying Solutions to Optimize Nutrition awards 3.75 CPEUs in accordance with the Commission on Dietetic Registration CPEU Approval.

CDR Activity Number: 189915 Self Study Activity Type: 741 Enduring Activity

CPE Level: II

Suggested CDR Performance Indicators:

        • 1.1.5 Integrates new knowledge and skills into practice.
        • 5.2.5 Analyzes and synthesizes information and identifies new information, patterns and findings.
        • 9.2.3 Seeks and analyzes new scientific information and how it impacts medical nutrition therapy.
        • 11.3.3 Prioritizes specific nutrition problems to inform nutrition care plans and processes.

Numerous other Performance Indicators may apply.

This self-study course includes required reading, a downloadable course document and an online exam with multiple choice questions. Upon passing the test, the learner can download and print the certificate.

Required Reading for this Course: Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. (A link to the article is included in the downloadable course document).

Disclaimer: The text associated with this course is required solely for the course taker to learn the underlying principles that will be applied in taking a case-study based exam. Neither the authors nor the publishers of the text/book have contributed to or endorsed this course.

Reviews

There are no reviews yet.

Be the first to review “GLP-1 Therapy for Patients with Obesity: Identifying Solutions to Optimize Nutrition”

Your email address will not be published. Required fields are marked *

This continuing education program reviews important aspects of supporting patients with obesity who are prescribed GLP-1 medication. It is a timely and informative course for nutrition professionals, especially those working with this patient population. The case study format provides real-life application, while the exam questions highlight relevant nutrition-related concerns.
- GLP-1 Therapy for Patients with Obesity: Identifying Solutions to Optimize Nutrition
Aimee Shea, MPH, RDN, CCMS, LD
Becky Dorner & Associates programs provide in-depth continuing education for nutrition professionals. Their courses cover a wide variety of interesting and pertinent topics that will help practitioners maintain up-to-date knowledge and expertise.
- Aimee Shea, MPH, RDN, CCMS, LD

Popular Products